79E-96618-61261
3 vaccinations
1 coded response
28 check-ins
0 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 840 / UT
- Registered
- 2022-06-29
- Relationship
- Child or adolescent in my care
- Guardian
- QN8-13354-37463
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-25
Dose 1 — Pfizer-BioNTech
-
2022-06-29
Registered in v-safe
- 2022-06-29
- 2022-06-30
- 2022-07-01
- 2022-07-04
- 2022-07-11
-
2022-07-16
Dose 2 — Pfizer-BioNTech
- 2022-07-16
- 2022-07-17
- 2022-07-18
- 2022-07-19
- 2022-07-20
- 2022-07-21
- 2022-07-23
- 2022-08-01
- 2022-08-06
- 2022-08-15
- 2022-08-20
- 2022-08-29
- 2022-10-15
- 2023-01-14
-
2023-01-24
Dose 3 — Pfizer-BioNTech
- 2023-01-25
- 2023-01-28
- 2023-01-29
- 2023-01-30
- 2023-01-31
-
2023-02-09
Survey response — day 14, dose 3, dependentMedDRA: Nasopharyngitis — Feeling: FairMedDRA releases: 2024-11
- 2023-02-14
- 2023-03-07
- 2023-04-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-25 | Pfizer-BioNTech | No |
| 2 | 2022-07-16 | Pfizer-BioNTech | No |
| 3 | 2023-01-24 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release